Cen BiotechCENBF
13F holders, Q2 2025 (June 30)2holders +1
1new positions
0sold out
$0.00avg. 13F price*
At the end of Q2 2025, 2 institutions reported holding Cen Biotech Inc. (CENBF) in their 13F filings, up 1 from Q1 2025. 1 opened new positions and 0 sold out. The largest holders were MassMutual Private Wealth & Trust, FSB ($0) and Ascentis Wealth Management, LLC ($0).
- Company
- Cen Biotech Inc.
- CUSIP
- 15130L104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 35 shares bought, net +35 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| MassMutual Private Wealth & Trust, FSB | 0.00% | No change | 1 | $0 |
| Ascentis Wealth Management, LLC | 0.00% | New | 35 | $0 |
"% of holder's portfolio" is CENBF's weight in each manager's 13F, not the share of Cen Biotech Inc. the manager owns.